Streetbeat News

Analyst Ratings

DNA

Ginkgo Bioworks Holdings (NYSE:DNA) has received mixed reviews from financial analysts, with 2 bearish and 2 indifferent ratings in the past quarter. The average 12-month price target is $1.8, up from the previous $1.25, with a high estimate of $2.50 and a low of $1.10. Goldman Sachs analyst Matthew Sykes lowered the price target to $1.10 from $1.25, maintaining a 'Sell' rating, while Raymond James analyst Rahul Sarugaser announced a 'Market Perform' rating with a $2.50 target. Ginkgo Bioworks faces challenges with a -16.52% revenue decline, a net margin of -546.44%, and an ROE of -21.98%, but maintains a low debt-to-equity ratio of 0.32.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 4:00 pm

SEMR

SEMrush Hldgs (NYSE:SEMR) received mixed analyst ratings over the past three months, with 1 bullish and 3 indifferent ratings. The average 12-month price target is $12.75, up from $11.67, with a high of $15.00 and a low of $10.00. Analysts from Goldman Sachs, Piper Sandler, Needham, and Morgan Stanley have updated their ratings and price targets. SEMrush's financials show strong market capitalization, revenue growth, net margin, ROE, ROA, and a low debt-to-equity ratio, indicating solid financial health and market confidence.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 4:00 pm

ZION

RBC Capital analyst Jon Arfstrom has reiterated a 'Sector Perform' rating on Zions Bancorp (NASDAQ:ZION) and maintained a price target of $45.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 3:55 pm

UUUU

Roth MKM analyst Joe Reagor has maintained a Buy rating on Energy Fuels (AMEX:UUUU) and increased the price target from $9.25 to $10.5 as reported on January 22, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 3:55 pm

PR

RBC Capital analyst Scott Hanold has reiterated an Outperform rating on Permian Resources (NYSE:PR) and maintained a $17 price target on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 3:52 pm

SAM

Roth MKM analyst Bill Kirk has maintained a Buy rating on Boston Beer Co (NYSE:SAM) and increased the price target from $406 to $422.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 3:51 pm

FHI

RBC Capital analyst Kenneth Lee has maintained a 'Sector Perform' rating on Federated Hermes (NYSE:FHI) and increased the price target from $34 to $36.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 3:50 pm

WTFC

UBS analyst Vilas Abraham has maintained a Buy rating on Wintrust Financial Corporation (NASDAQ:WTFC) and increased the price target from $105 to $113.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 3:42 pm

TRV

UBS analyst Brian Meredith has maintained a Neutral rating on Travelers Companies (NYSE:TRV) and increased the price target from $205 to $225.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 3:39 pm

TCBI

UBS analyst Brody Preston has maintained a Sell rating on Texas Capital Bancshares (NASDAQ:TCBI) but increased the price target from $56 to $57.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 3:35 pm